The information in this article is not intended to replace any recommendations or relationship with your physician
While the cancer risk is the most talked-about issue, a more common practical concern involves those already being treated for hypothyroidism (an underactive thyroid)
Average weight loss in the treatment group was 13.6% body weight, compared to 2.4% in the placebo group
Weight loss typically follows a pattern: a modest initial drop (often partially water weight), followed by steady fat loss of 1 to 2 pounds per week at therapeutic doses
Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L
These results are broadly in line with what has been seen with the weekly Wegovy injection, supporting the view that the tablet offers a comparable alternative for suitable patients